F/M Investments’s LeMaitre Vascular LMAT Stock Holding History

F/M Investments’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,534	Closed	-$2.88M	–	398
2025 Q4	$2.88M	Sell	35,534 -2,437	-6%	-$210K	0.11%	199
2025 Q3	$3.32M	Sell	37,971 -9,223	-20%	-$824K	0.13%	178
2025 Q2	$3.92M	Buy	47,194 +1,294	+3%	+$108K	0.14%	156
2025 Q1	$3.85M	Buy	45,900 +7,274	+19%	+$677K	0.15%	149
2024 Q4	$3.56M	Sell	38,626 -84,919	-69%	-$8.17M	0.13%	156
2024 Q3	$11.5M	Buy	123,545 +33,087	+37%	+$2.87M	0.36%	86
2024 Q2	$7.44M	Buy	+90,458	New	+$6.65M	0.27%	126

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

F/M Investments's LMAT Position: Q1 2026 in Review

F/M Investments sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 35,534 shares — an estimated $2.88M sold.

F/M Investments first reported a position in LMAT in Q2 2024 and held it in 7 quarters. The position peaked at $11.5M in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

F/M Investments reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
F/M Investments sold 35,534 LeMaitre Vascular shares in Q1 2026, an estimated $2.88M.
F/M Investments first reported a position in LeMaitre Vascular in Q2 2024 and held it in 7 quarters.
F/M Investments's LeMaitre Vascular position peaked at $11.5M in Q3 2024.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.